Perioperative Care of Transurethral Resection

Effects of DexmedetomidineInfusion on the Recovery Profiles of Patients Undergoing Transurethral Resection

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0001683

Enrollment

Registered

2015-10-30

Start date

2012-09-13

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Patients were mechanically ventilated to maintain end tidal carbon dioxide partial pressure of 30–40 mmHg. Simultaneously with the induction of anesthesia, a loading dose of 0.5 µg/kg dexmedeto

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: All patients provided written informed consent. Sixty male patients aged 30 to 80 years with American Society of Anesthesiologists status I or II who were scheduled forelective transurethral resection under general anesthesia were included in this study. Participants were randomly assigned to two groups.

Exclusion criteria

Exclusion criteria: Patients with severe cardiovascular, neurologic, renal, or hepatic disorders,and those who were taking psychoactive drugs were excluded.

Design outcomes

Primary

Measure	Time frame
emergence agitation score	—

Secondary

Measure	Time frame
Catheter induced bladder discomfort, bradycardia, hypotension, nausea and vomiting	—

Countries

Korea, Republic of

Contacts

Public ContactSo Young Kwon

The Catholic University of Korea

manji80@hanmail.net

Outcome results